These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 32699047)

  • 1. Klotho in Clinical Nephrology: Diagnostic and Therapeutic Implications.
    Neyra JA; Hu MC; Moe OW
    Clin J Am Soc Nephrol; 2020 Dec; 16(1):162-176. PubMed ID: 32699047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. αKlotho and Chronic Kidney Disease.
    Neyra JA; Hu MC
    Vitam Horm; 2016; 101():257-310. PubMed ID: 27125746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implications of Klotho Protein for Managing Kidney Disease - an Emerging Role in Therapeutics and Molecular Medicine.
    Ray SK; Masarkar N; Mukherjee S
    Curr Mol Med; 2021; 21(6):484-494. PubMed ID: 33222666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant α-Klotho may be prophylactic and therapeutic for acute to chronic kidney disease progression and uremic cardiomyopathy.
    Hu MC; Shi M; Gillings N; Flores B; Takahashi M; Kuro-O M; Moe OW
    Kidney Int; 2017 May; 91(5):1104-1114. PubMed ID: 28131398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The emerging role of Klotho in clinical nephrology.
    Hu MC; Kuro-o M; Moe OW
    Nephrol Dial Transplant; 2012 Jul; 27(7):2650-7. PubMed ID: 22802580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential application of klotho in human chronic kidney disease.
    Neyra JA; Hu MC
    Bone; 2017 Jul; 100():41-49. PubMed ID: 28115282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of klotho in chronic kidney disease.
    Zou D; Wu W; He Y; Ma S; Gao J
    BMC Nephrol; 2018 Oct; 19(1):285. PubMed ID: 30348110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The intersection of mineralocorticoid receptor activation and the FGF23-Klotho cascade: a duopoly that promotes renal and cardiovascular injury.
    Epstein M; Freundlich M
    Nephrol Dial Transplant; 2022 Jan; 37(2):211-221. PubMed ID: 34459924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble Klotho, a Potential Biomarker of Chronic Kidney Disease-Mineral Bone Disorders Involved in Healthy Ageing: Lights and Shadows.
    Martín-Vírgala J; Martín-Carro B; Fernández-Villabrille S; Ruiz-Torres MP; Gómez-Alonso C; Rodríguez-García M; Fernández-Martín JL; Alonso-Montes C; Panizo S; Cannata-Andía JB; Naves-Díaz M; Carrillo-López N
    Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FGF23: From academic nephrology to personalized patients' care.
    González-Casaus ML; Gonzalez-Parra E; Fernandez-Calle P; Buño-Soto A
    Nefrologia (Engl Ed); 2021; 41(3):276-283. PubMed ID: 36166244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Potential application of fibroblast growth factor 23-klotho axis in chronic kidney disease].
    Lacroix JS; Urena-Torres P
    Nephrol Ther; 2020 Mar; 16(2):83-92. PubMed ID: 31843356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblast Growth Factor 23 and Klotho in AKI.
    Christov M; Neyra JA; Gupta S; Leaf DE
    Semin Nephrol; 2019 Jan; 39(1):57-75. PubMed ID: 30606408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast growth factor 23/klotho axis in chronic kidney disease.
    Nitta K; Nagano N; Tsuchiya K
    Nephron Clin Pract; 2014; 128(1-2):1-10. PubMed ID: 25402964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Klotho and kidney disease.
    Hu MC; Kuro-o M; Moe OW
    J Nephrol; 2010; 23 Suppl 16(Suppl 16):S136-44. PubMed ID: 21170871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Klotho/FGF23 Axis in Chronic Kidney Disease and Cardiovascular Disease.
    Lu X; Hu MC
    Kidney Dis (Basel); 2017 Jul; 3(1):15-23. PubMed ID: 28785560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Klotho and calciprotein particles as therapeutic targets against accelerated ageing.
    Kuro-O M
    Clin Sci (Lond); 2021 Aug; 135(15):1915-1927. PubMed ID: 34374422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Klotho/FGF23 and Wnt Signaling as Important Players in the Comorbidities Associated with Chronic Kidney Disease.
    Muñoz-Castañeda JR; Rodelo-Haad C; Pendon-Ruiz de Mier MV; Martin-Malo A; Santamaria R; Rodriguez M
    Toxins (Basel); 2020 Mar; 12(3):. PubMed ID: 32188018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal and extrarenal actions of Klotho.
    Hu MC; Kuro-o M; Moe OW
    Semin Nephrol; 2013 Mar; 33(2):118-29. PubMed ID: 23465499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FGF23 and klotho at the intersection of kidney and cardiovascular disease.
    Edmonston D; Grabner A; Wolf M
    Nat Rev Cardiol; 2024 Jan; 21(1):11-24. PubMed ID: 37443358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. α-Klotho's effects on mineral homeostasis are fibroblast growth factor-23 dependent.
    Erben RG
    Curr Opin Nephrol Hypertens; 2018 Jul; 27(4):229-235. PubMed ID: 29851418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.